CORMEDIX INC WTS EXP 04/30/15
CRMD.WS
CRMD.WS was delisted on the 29th of April, 2015.
3 hedge funds and large institutions have $11K invested in CORMEDIX INC WTS EXP 04/30/15 in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
68% less capital invested
Capital invested by funds: $34K → $11K (-$23K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$104 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$4.96K |
CRMD.WS Hedge Fund Activity: Q3 2013 in Review
3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) for Q3 2013, worth a combined $11K — down 68% from $34K a quarter earlier.
Fund positioning in CRMD.WS was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS, adding an estimated $104. The largest seller was AQR Capital Management, cutting an estimated $4.96K.
- 3 institutional investors held CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $11K of CORMEDIX INC WTS EXP 04/30/15 stock for Q3 2013, down 68% quarter-over-quarter.
- 0 funds opened new CORMEDIX INC WTS EXP 04/30/15 positions in Q3 2013 and 0 closed out.
- The largest CORMEDIX INC WTS EXP 04/30/15 buyer in Q3 2013 was UBS, an estimated $104 added.
- The largest CORMEDIX INC WTS EXP 04/30/15 seller in Q3 2013 was AQR Capital Management, an estimated $4.96K sold.
Based on aggregated 13F filings for Q3 2013.